GO:0008305 integrin complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008305 integrin complex is a heterodimeric cell-surface adhesion receptor composed of one alpha subunit and one beta subunit that spans the plasma membrane and binds extracellular matrix, cell-surface, and soluble ligands.
• Integrin complexes are non-covalent heterodimers; in humans, 18 alpha subunits and 8 beta subunits assemble into 24 distinct receptors with overlapping and specific ligand-binding profiles.
• Ligand binding triggers large-scale conformational changes (bent to extended, closed to open headpiece) that convert the complex into a signaling-competent state, a process known as inside-out and outside-in signaling.
• Integrin complexes nucleate adhesome assemblies, including talin, kindlin, paxillin, vinculin, and actin, which are organized into nanoscale layers that transmit force and control cell migration and invasion.
• Dysregulated integrin complexes contribute to cancer progression, fibrosis, immune disorders, and osteoarthritis, making them major therapeutic targets.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of integrin subunit function, while CRISPR library screening and bioinformatics identify pathway vulnerabilities.
Description
The integrin complex (GO:0008305) is a plasma membrane-spanning heterodimeric receptor composed of one alpha subunit and one beta subunit, both members of the integrin superfamily of cell adhesion receptors. This complex is the principal means by which cells physically engage the extracellular matrix (ECM), neighboring cell-surface ligands, and soluble ligands, thereby converting mechanical and chemical cues into intracellular signals. Because integrins sit at the interface between the cell and its environment, they are central to adhesion, migration, proliferation, survival, and differentiation. From a research perspective, the integrin complex is both a structural entity and a signaling hub. Its ligand-binding ectodomain, single-pass transmembrane helices, and short cytoplasmic tails coordinate bidirectional signaling: inside-out activation, in which intracellular activators such as talin and kindlin increase ligand affinity, and outside-in signaling, in which ligand engagement reorganizes the cytoskeleton and recruits signaling and adaptor proteins. These properties make integrin complexes tractable targets for genetic perturbation and high-content imaging. This article summarizes the authoritative QuickGO definition of GO:0008305, its subunit composition, activation mechanism, associated genes, disease relevance, and the experimental methods, including CRISPR-based models, used to study integrin biology. All statements are supported by the verified literature cited by number.
integrin complex At A Glance
| GO ID | GO:0008305 |
|---|---|
| GO term | integrin complex |
| Ontology | cellular_component |
| Synonym | laminin receptor protein |
| Definition | A protein complex composed of one alpha subunit and one beta subunit, both members of the integrin superfamily of cell adhesion receptors; the complex spans the plasma membrane and binds to extracellular matrix ligands, cell-surface ligands, and soluble ligands. |
| Major function | Cell adhesion to extracellular matrix and cell-surface ligands, bidirectional transmembrane signaling, mechanotransduction, and regulation of migration, proliferation, and survival. |
| Subunit composition | Non-covalent heterodimer of one alpha subunit and one beta subunit; 18 alpha and 8 beta subunits in humans form 24 distinct heterodimers. |
| Cellular location | Plasma membrane, with a large extracellular ligand-binding ectodomain, a single-pass transmembrane region, and a short cytoplasmic tail. |
| Representative ligands | Extracellular matrix proteins (collagen, fibronectin, laminin), cell-surface ligands (ICAMs, VCAM-1), and soluble ligands. |
What Is GO:0008305?
According to the Gene Ontology, GO:0008305 (integrin complex) is a protein complex composed of one alpha subunit and one beta subunit, both members of the integrin superfamily of cell adhesion receptors; the complex spans the plasma membrane and binds to extracellular matrix ligands, cell-surface ligands, and soluble ligands. The synonym laminin receptor protein reflects the historical observation that certain integrin heterodimers bind laminin. In practical terms, an integrin complex is a non-covalent alpha-beta heterodimer that functions as a transmembrane adhesion and signaling receptor.
Why Is integrin complex Important in Cell Biology?
The integrin complex is essential because it is the primary molecular bridge between the extracellular environment and the intracellular cytoskeleton and signaling machinery. Integrin-mediated adhesion controls cell shape, migration, proliferation, survival, and differentiation, and it is required for tissue development and homeostasis. Because integrin complexes are frequently dysregulated in cancer, fibrosis, immune disorders, and osteoarthritis, they are among the most actively pursued therapeutic targets in translational research.
• Integrin complexes mediate cell adhesion to the extracellular matrix and to cell-surface ligands, anchoring cells and organizing tissues.
• They transmit mechanical force across the plasma membrane and participate in mechanotransduction.
• They regulate cell migration and invasion, processes central to development, wound healing, and cancer metastasis.
• They control proliferation and survival signaling through focal adhesion kinase, Src, and integrin-linked kinase pathways.
• They contribute to immune cell trafficking and inflammation through binding to cell-surface ligands such as ICAMs and VCAM-1.
• Dysregulated integrin complexes are implicated in cancer progression, fibrosis, and osteoarthritis.
• Integrin complexes are targets for therapeutic antibodies, small molecules, and peptide inhibitors.
• They interact functionally with ion channels, expanding their signaling repertoire.
• They are tractable for CRISPR knockout, point-mutation, knock-in, and overexpression studies.
• They serve as model systems for studying nanoscale adhesome architecture.
integrin complex
Biosynthesis and heterodimer assembly
In simple terms: The alpha and beta subunits are made separately and then pair up inside the cell before traveling to the surface.
Integrin alpha and beta subunits are synthesized in the endoplasmic reticulum and assemble into non-covalent heterodimers. Assembly is subunit-specific: in humans, 18 alpha subunits and 8 beta subunits combine into 24 distinct integrin complexes with different ligand specificities. The heterodimer is the minimal functional unit of GO:0008305, and correct pairing is required for export to the plasma membrane.
Ligand binding and activation
In simple terms: When the integrin grabs a ligand outside the cell, it changes shape and becomes active.
Ligand binding occurs through the alpha subunit beta-propeller and the beta subunit I domain, often with a metal-ion-dependent adhesion site (MIDAS) that coordinates a glutamate from the ligand. Ligand engagement stabilizes an extended, open-headpiece conformation that is signaling-competent. This outside-in activation is coupled to inside-out activation, in which intracellular proteins such as talin and kindlin bind the beta-subunit cytoplasmic tail and increase ligand affinity.
Adhesome assembly and mechanotransduction
In simple terms: Once active, the integrin recruits a team of proteins that link it to the actin cytoskeleton and transmit force.
Activated integrin complexes nucleate the adhesome, a layered protein network that includes talin, kindlin, paxillin, vinculin, focal adhesion kinase, and actin regulators. Super-resolution imaging has revealed that the adhesome is organized into distinct nanoscale layers, with integrins at the membrane, an integrin-signaling layer, a force-transduction layer, and an actin-regulatory layer. This architecture allows the integrin complex to sense and respond to mechanical force.
Downstream signaling and crosstalk
In simple terms: The active integrin sends signals inside the cell and talks to other receptors.
Integrin ligation activates focal adhesion kinase, Src-family kinases, and integrin-linked kinase, which regulate proliferation, survival, and cytoskeletal remodeling. Integrin complexes also functionally interact with ion channels, forming complex signaling modules at the membrane. This crosstalk allows integrins to integrate adhesion signals with growth factor, cytokine, and electrical cues.
Trafficking and turnover
In simple terms: Integrins are constantly recycled or degraded, which lets cells change how sticky they are.
Integrin complexes are internalized through endocytic pathways and either recycled back to the plasma membrane or targeted for degradation, a process that controls adhesion dynamics during migration. Trafficking is regulated by Rab GTPases, Arf6, and adaptor proteins, and it determines the spatial distribution of active integrins at the leading edge and in focal adhesions.
Key Genes Involved in GO:0008305 integrin complex
The following genes encode the alpha and beta subunits and the principal cytoplasmic regulators of the integrin complex (GO:0008305).
| Gene | Major Role | Research Relevance |
|---|---|---|
| ITGA1 | Alpha-1 subunit; pairs with beta-1 to form collagen/laminin receptor | KO and knock-in models for collagen adhesion and fibrosis |
| ITGA2 | Alpha-2 subunit; collagen receptor with beta-1 | Point-mutation studies of MIDAS and ligand binding |
| ITGA3 | Alpha-3 subunit; laminin receptor with beta-1 | KO models for basement membrane adhesion |
| ITGA4 | Alpha-4 subunit; pairs with beta-1 or beta-7 for VCAM-1/fibronectin | Immune trafficking and inflammation models |
| ITGA5 | Alpha-5 subunit; fibronectin receptor with beta-1 | Classic model for adhesion and migration |
| ITGA6 | Alpha-6 subunit; laminin receptor with beta-4 | Knock-in reporters for hemidesmosome studies |
| ITGAV | Alpha-V subunit; binds RGD ligands with multiple beta subunits | Overexpression and KO models for angiogenesis and cancer |
| ITGB1 | Beta-1 subunit; pairs with many alpha subunits | Central node for adhesome and mechanotransduction studies |
| ITGB2 | Beta-2 subunit; leukocyte integrin (LFA-1, Mac-1) | Immune adhesion and inflammation models |
| ITGB3 | Beta-3 subunit; platelet integrin alpha-IIb/beta-3 and alpha-V/beta-3 | Point-mutation models for platelet function |
| ITGB4 | Beta-4 subunit; laminin receptor in hemidesmosomes | KO models for skin blistering and epithelial adhesion |
| ITGB5 | Beta-5 subunit; pairs with alpha-V | Knock-in models for RGD ligand specificity |
| TLN1 | Talin-1; activates beta-subunit cytoplasmic tail | KO and point-mutation studies of inside-out activation |
| FERMT2 | Kindlin-2; co-activator of integrin beta tails | KO models for integrin activation and development |
| PTK2 | Focal adhesion kinase; downstream integrin signaling | KO and knock-in models for adhesion signaling |
| VCL | Vinculin; links integrins to actin cytoskeleton | Tagged knock-in for adhesome imaging |
| PXN | Paxillin; adaptor in focal adhesions | KO models for migration and adhesion turnover |
| ILK | Integrin-linked kinase; scaffolds adhesome | KO models for integrin signaling and tissue homeostasis |
How Is integrin complex Regulated?
Integrin complex activity is regulated at multiple levels. Inside-out activation is controlled by the binding of talin and kindlin to the beta-subunit cytoplasmic tail, which is itself regulated by phosphorylation and by lipid binding. Ligand affinity is modulated by conformational changes and by divalent cations at the MIDAS motif. Expression levels are controlled transcriptionally and by microRNAs, while surface levels are governed by endocytic recycling and degradation. Integrin signaling also crosstalks with growth factor receptors and ion channels, providing additional layers of regulation. In joint tissues, integrin signaling is regulated during development and homeostasis, and its dysregulation contributes to osteoarthritis.
integrin complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ITGB1 | Cancer invasion and metastasis | CRISPR knockout in cancer cell lines followed by migration assays |
| ITGAV | Angiogenesis and tumor growth | Knock-in of RGD-binding mutations and xenograft models |
| ITGB2 | Leukocyte adhesion deficiency and inflammation | Point-mutation knock-in in immune cells |
| ITGB4 | Epidermolysis bullosa and epithelial adhesion | Knockout in keratinocytes and skin organoids |
| ITGA1 | Osteoarthritis and cartilage degradation | Knockout in chondrocytes and joint explants |
Cancer progression and metastasis
Integrin complexes are frequently overexpressed or functionally altered in cancer, where they promote proliferation, survival, migration, and invasion. Specific heterodimers, such as alpha-V/beta-3 and alpha-5/beta-1, support angiogenesis and metastatic dissemination, and they are targets for therapeutic antibodies and small-molecule inhibitors. The adhesome architecture downstream of integrins also influences invasive behavior.
Osteoarthritis and joint disease
Integrin signaling is essential for joint development and homeostasis, and its dysregulation contributes to osteoarthritis. Integrin complexes in chondrocytes mediate mechanotransduction and matrix interactions, and altered integrin signaling is associated with cartilage degradation.
Immune and inflammatory disorders
Leukocyte integrins such as LFA-1 (alpha-L/beta-2) and VLA-4 (alpha-4/beta-1) control immune cell adhesion and trafficking. Dysregulated integrin function contributes to autoimmune and inflammatory diseases, and integrin-blocking antibodies are used clinically in inflammatory conditions.
Fibrosis and tissue remodeling
Integrin complexes mediate fibroblast adhesion to ECM and activate latent TGF-beta, promoting fibrosis. Targeting integrin complexes is being explored to limit fibrotic remodeling in lung, liver, and kidney disease.
From integrin complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is the integrin subunit required for adhesion and migration? | CRISPR knockout cell line plus ECM adhesion and wound-healing assays |
| Does a specific residue control ligand binding? | Point-mutation knock-in of the MIDAS or ligand-binding site |
| Where and when is the integrin complex expressed? | Tagged knock-in reporter (e.g., fluorescent tag) and live imaging |
| Does overexpression drive invasion? | Doxycycline-inducible overexpression in epithelial cells |
| Which genes buffer integrin loss? | Genome-wide CRISPR library screening with adhesion-based selection |
| How does force change adhesome composition? | Knock-in of mechanosensitive reporters and super-resolution imaging |
How to Study the integrin complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotype | Testing requirement of an integrin subunit for adhesion |
| Point-mutation knock-in | Effect of a specific residue | Dissecting MIDAS and ligand-binding residues |
| Tagged knock-in | Protein localization and dynamics | Live imaging of integrin complexes |
| Overexpression | Gain-of-function phenotype | Driving invasion or angiogenesis in vitro |
| Super-resolution microscopy | Nanoscale adhesome architecture | Mapping integrin signaling layers |
| Proximity proteomics | Integrin-associated protein network | Defining adhesome composition |
| CRISPR library screening | Genome-wide dependencies | Identifying modifiers of integrin-mediated adhesion |
| Bioinformatics | Pathway and network signatures | Prioritizing integrin targets from omics data |
Genetic perturbation with CRISPR
CRISPR knockout, point mutation, knock-in, and overexpression allow causal testing of integrin subunit function. Knockout of ITGB1 or ITGAV, for example, reduces adhesion and migration, while point mutations in the ligand-binding site dissect affinity versus signaling.
Adhesion and migration assays
ECM-coated surfaces, transwell assays, and live-cell imaging measure adhesion strength, migration speed, and invasion capacity of cells with altered integrin complexes. These assays are typically paired with CRISPR-edited lines to link genotype to phenotype.
Super-resolution and live-cell imaging
Super-resolution microscopy resolves the nanoscale layers of the adhesome, including integrin, talin, vinculin, and actin, and reveals how force changes their organization. Tagged knock-in reporters enable dynamic tracking of integrin complexes in living cells.
Proteomics and bioinformatics
Affinity purification and proximity labeling coupled to mass spectrometry identify integrin-associated proteins and adhesome components. Bioinformatics analysis of CRISPR screening data and transcriptomic profiles identifies integrin pathway dependencies and candidate regulators.
How CRISPR Can Be Used to Study GO:0008305 integrin complex
Knockout
CRISPR knockout of integrin subunit genes such as ITGB1, ITGAV, or ITGA5 abolishes the corresponding heterodimer and produces loss-of-adhesion phenotypes, making it the first-line approach to test requirement in migration, invasion, and signaling. Knockout of cytoplasmic regulators such as TLN1 or PTK2 similarly disrupts integrin function.
Point Mutation
Point-mutation knock-in can alter specific residues in the ligand-binding site, the MIDAS motif, or the cytoplasmic tail to separate ligand binding from signaling. This approach is valuable for testing whether a disease-associated variant acts through altered affinity, activation, or downstream coupling.
Knock-in
Knock-in of fluorescent or epitope tags into endogenous integrin loci enables live imaging and proteomic analysis of the integrin complex in its native context. Knock-in of disease variants or reporter cassettes also allows physiological expression-level studies.
Overexpression
Overexpression of specific alpha-beta pairs, such as alpha-V/beta-3 or alpha-5/beta-1, drives adhesion, migration, and angiogenesis in vitro and in vivo, and is used to model integrin-driven cancer phenotypes. Inducible overexpression systems provide temporal control.
How EDITGENE Supports integrin complex Research
Researchers studying integrin complex-related genes often need to determine whether a candidate gene is causally involved in adhesion, migration, or disease progression. EDITGENE provides publication-ready CRISPR models and screening services that make these causal tests efficient and reproducible.
Contact EDITGENE today to design your custom CRISPR model for integrin complex research.
Frequently Asked Questions About integrin complex
What is GO:0008305 integrin complex?
GO:0008305 is the Gene Ontology term for a protein complex composed of one alpha subunit and one beta subunit, both members of the integrin superfamily; it spans the plasma membrane and binds extracellular matrix, cell-surface, and soluble ligands.
What genes are involved in the integrin complex?
The complex is encoded by alpha-subunit genes such as ITGA1, ITGA2, ITGA3, ITGA4, ITGA5, ITGA6, and ITGAV, and beta-subunit genes such as ITGB1, ITGB2, ITGB3, ITGB4, and ITGB5, with regulators including TLN1, FERMT2, PTK2, VCL, PXN, and ILK.
How many integrin heterodimers exist in humans?
In humans, 18 alpha subunits and 8 beta subunits assemble into 24 distinct integrin heterodimers.
What is the function of the integrin complex?
It mediates cell adhesion to the extracellular matrix and cell-surface ligands, transmits mechanical force, and activates intracellular signaling that controls migration, proliferation, survival, and differentiation.
How is the integrin complex activated?
Activation involves conformational changes from a bent, closed state to an extended, open state; inside-out activation is driven by talin and kindlin binding to the beta-subunit tail, while ligand binding stabilizes the active state.
What diseases are linked to integrin complexes?
Integrin complexes are implicated in cancer progression and metastasis, osteoarthritis, immune and inflammatory disorders, and fibrosis.
How do you study integrin complexes with CRISPR?
CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression models allow causal testing of integrin subunit and regulator function in adhesion, migration, and signaling assays.
What is the adhesome?
The adhesome is the layered network of proteins, including talin, kindlin, paxillin, vinculin, and actin regulators, that assembles around activated integrin complexes and transmits force.
Which integrins bind laminin?
Several integrin heterodimers, including alpha-3/beta-1, alpha-6/beta-1, and alpha-6/beta-4, bind laminin; the synonym laminin receptor protein reflects this historical ligand association.
Why are integrins important drug targets?
Because they drive cancer, inflammation, and fibrosis, integrin complexes are targeted by therapeutic antibodies, small molecules, and peptide inhibitors in clinical and preclinical development.
Conclusion
The integrin complex (GO:0008305) is a central cell-surface adhesion and signaling machine built from one alpha and one beta subunit. Its ability to bind diverse ligands, change conformation, and nucleate the adhesome makes it essential for development, homeostasis, and disease. Understanding its components, assembly, and regulation provides a foundation for therapeutic targeting in cancer, inflammation, fibrosis, and osteoarthritis. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with imaging, proteomics, and library screening, now allow precise causal dissection of integrin biology. These approaches accelerate the translation of integrin discoveries into new treatments.
References
- 1. Pang X et al.. 2023. Targeting integrin pathways: mechanisms and advances in therapy.. Signal Transduct Target Ther 8(1):1 PMID: 36588107
- 2. Campbell ID et al.. 2011. Integrin structure, activation, and interactions.. Cold Spring Harb Perspect Biol 3(3) PMID: 21421922
- 3. Kanchanawong P et al.. 2010. Nanoscale architecture of integrin-based cell adhesions.. Nature 468(7323):580-4 PMID: 21107430
- 4. Bella J et al.. 2000. Integrin-collagen complex: a metal-glutamate handshake.. Structure 8(6):R121-6 PMID: 10873865
- 5. Arcangeli A et al.. 2006. Complex functional interaction between integrin receptors and ion channels.. Trends Cell Biol 16(12):631-9 PMID: 17064899
- 6. Chastney MR et al.. 2025. The role and regulation of integrins in cell migration and invasion.. Nat Rev Mol Cell Biol 26(2):147-167 PMID: 39349749
- 7. Humphries MJ. 2000. Integrin structure.. Biochem Soc Trans 28(4):311-39 PMID: 10961914
- 8. Miao MZ et al.. 2024. Integrin signalling in joint development, homeostasis and osteoarthritis.. Nat Rev Rheumatol 20(8):492-509 PMID: 39014254
